» Articles » PMID: 19460098

Evidence That CT694 is a Novel Chlamydia Trachomatis T3S Substrate Capable of Functioning During Invasion or Early Cycle Development

Overview
Journal Mol Microbiol
Date 2009 May 23
PMID 19460098
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Chlamydia trachomatis is an obligate intracellular parasite, occupies a membrane-bound vacuole throughout development and is capable of manipulating the eukaryotic host by translocating effector molecules via a type III secretion system (T3SS). The infectious chlamydial elementary body (EB) is metabolically inactive yet possesses a functional T3S apparatus capable of translocating effector proteins into the host cell to facilitate invasion and other early cycle events. We present evidence here that the C. trachomatis protein CT694 represents an early cycle-associated effector protein. CT694 is secreted by the Yersinia T3SS and immunodetection studies of infected HeLa cultures indicate that CT694-specific signal accumulates directly adjacent to, but not completely overlapping with EBs during invasion. Yeast two-hybrid analyses revealed an interaction of CT694 with the repeat region and C-terminus of human AHNAK. Immunolocalization studies of CT694 ectopically expressed in HeLa cells were consistent with an interaction with endogenous AHNAK. Additionally, expression of CT694 in HeLa cells resulted in alterations in the detection of stress fibres that correlated with the ability of CT694 to interact with AHNAK. These data indicate that CT694 is a novel T3S-dependent substrate unique to C. trachomatis, and that its interaction with host proteins such as AHNAK may be important for aspects of invasion or development particular to this species.

Citing Articles

Insights into Chlamydia Development and Host Cells Response.

Yang S, Zeng J, Yu J, Sun R, Tuo Y, Bai H Microorganisms. 2024; 12(7).

PMID: 39065071 PMC: 11279054. DOI: 10.3390/microorganisms12071302.


Identification of homologs of the Chlamydia trachomatis effector CteG reveals a family of Chlamydiaceae type III secreted proteins that can be delivered into host cells.

Pereira I, da Cunha M, Leal I, Luis M, Goncalves P, Goncalves C Med Microbiol Immunol. 2024; 213(1):15.

PMID: 39008129 PMC: 11249467. DOI: 10.1007/s00430-024-00798-9.


Plasmid-mediated virulence in .

Turman B, Darville T, OConnell C Front Cell Infect Microbiol. 2023; 13:1251135.

PMID: 37662000 PMC: 10469868. DOI: 10.3389/fcimb.2023.1251135.


TmeB antagonizes actin polymerization via direct interference with Arp2/3 activity.

Scanlon K, Keb G, Wolf K, Jewett T, Fields K Front Cell Infect Microbiol. 2023; 13:1232391.

PMID: 37483386 PMC: 10360934. DOI: 10.3389/fcimb.2023.1232391.


Type III Secretion in .

Rucks E Microbiol Mol Biol Rev. 2023; 87(3):e0003423.

PMID: 37358451 PMC: 10521360. DOI: 10.1128/mmbr.00034-23.


References
1.
de Jonge B, Chang Y, Gage D, Tomasz A . Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. The role of penicillin binding protein 2A. J Biol Chem. 1992; 267(16):11248-54. View

2.
Wissel M, Wendt J, Mitchell C, Weiss D . The transmembrane helix of the Escherichia coli division protein FtsI localizes to the septal ring. J Bacteriol. 2004; 187(1):320-8. PMC: 538840. DOI: 10.1128/JB.187.1.320-328.2005. View

3.
Weiss D, Chen J, Ghigo J, Boyd D, Beckwith J . Localization of FtsI (PBP3) to the septal ring requires its membrane anchor, the Z ring, FtsA, FtsQ, and FtsL. J Bacteriol. 1999; 181(2):508-20. PMC: 93405. DOI: 10.1128/JB.181.2.508-520.1999. View

4.
Pinho M, de Lencastre H, Tomasz A . An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci. Proc Natl Acad Sci U S A. 2001; 98(19):10886-91. PMC: 58569. DOI: 10.1073/pnas.191260798. View

5.
Tomasz A, JAMIESON J, OTTOLENGHI E . THE FINE STRUCTURE OF DIPLOCOCCUS PNEUMONIAE. J Cell Biol. 1964; 22:453-67. PMC: 2106453. DOI: 10.1083/jcb.22.2.453. View